Cameron J. Turtle

Also affiliated with Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa, Royal North Shore Hospital, Fred Hutch Cancer Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 32 papers. Top paper: “Toxicities of CD19 CAR‐T cell immunotherapy”.

Toxicities of CD19 CAR‐T cell immunotherapy

American Journal of Hematology(2019)10.1002/ajh.25445

N/A

6.3DataRank · unranked

139 citations

Cameron J. Turtle, Alexandre V. Hirayama

Insight into mechanisms associated with cytokine release syndrome and neurotoxicity after CD19 CAR-T cell immunotherapy

Bone Marrow Transplantation(2019)10.1038/s41409-019-0602-5

N/A

3.0DataRank · unranked

77 citations

Cameron J. Turtle, Cassie K. Chou

γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial

The Lancet Oncology(2023)10.1016/s1470-2045(23)00246-2

N/A

2.5DataRank · unranked

101 citations

Margot J. Pont, Blythe Sather, Cameron J. Turtle, Brian G. Till, Edward N. Libby +15 more

Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023011287

N/A

1.7DataRank · unranked

55 citations

Erik L. Kimble, Jocelyn H. Wright, Salvatore Fiorenza, Jordan Gauthier, Jenna Voutsinas +18 more

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL

Blood Advances(2023)10.1182/bloodadvances.2023011399

N/A

0.958DataRank · unranked

34 citations

Aya Albittar, Jennifer J. Huang, Alexandre V. Hirayama, Erik L. Kimble, Andrew J. Portuguese +11 more

Evidence generation and reproducibility in cell and gene therapy research: A call to action

Molecular Therapy - Methods & Clinical Development(2021)10.1016/j.omtm.2021.06.012

N/A

0.934DataRank · unranked

24 citations

Aris Angelis, Frederick R. Appelbaum, Nancy C. Andrews, Susan E. Bates, Arlene S. Bierman +33 more

Unveiling the autoreactome: Proteome-wide immunological fingerprints reveal the promise of plasma cell depleting therapy

medRxiv(2023)10.1101/2023.12.19.23300188

N/A

0.637DataRank · unranked

7 citations

David Yu, Alysa Rallistan, Müge Kalaycıoğlu, Jim Boonyaratanakornkit, Damian J. Green +28 more

The chimeric antigen receptor-intensive care unit (CAR-ICU) initiative: Surveying intensive care unit practices in the management of CAR T-cell associated toxicities

Journal of Critical Care(2020)10.1016/j.jcrc.2020.04.008

N/A

0.604DataRank · unranked

55 citations

Anne Rain Brown, Megan M. Herr, Sameer S. Kadri, Brian T. Hill, Prabalini Rajendram +22 more

Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALL

Blood Advances(2025)10.1182/bloodadvances.2024015314

N/A

0.447DataRank · unranked

10 citations

Emily C. Liang, Jennifer J. Huang, Erik L. Kimble, Alexandre V. Hirayama, Salvatore Fiorenza +15 more

A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy

Blood Advances(2022)10.1182/bloodadvances.2022008697

N/A

0DataRank · unranked

26 citations

Cassie Chou, Takahiro Miyazaki, Rachel N. Steinmetz, Henna A Di, Simon P. Fraessle +8 more

Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.04.001

N/A

0DataRank · unranked

140 citations

Emily C. Liang, Qian Wu, Jenna Voutsinas, Pere Barba, Gloria Iacoboni +19 more

Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy: a prospective observational study

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003428

N/A

0DataRank · unranked

45 citations

Andrea N. Loes, Kiel Shuey, Elizabeth M. Krantz, Jim Boonyaratanakornkit, Jacob Keane-Candib +13 more

Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies

JCI Insight(2021)10.1172/jci.insight.146743

N/A

0DataRank · unranked

62 citations

Elizabeth M. Krantz, Joyce Maalouf, Jim Boonyaratanakornkit, Jacob Keane-Candib, Laurel Joncas-Schronce +13 more

Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy

American Journal of Transplantation(2023)10.1016/j.ajt.2022.11.001

N/A

0DataRank · unranked

23 citations

Erika S. Kiem, Atif Bhatti, Winnie Liu, Jacob Keane-Candib, Kristin Fitzpatrick +10 more

Five-year follow-up update of defined-composition CD19 CAR T-cell therapy for relapsed/refractory CLL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7511

N/A

0DataRank · unranked

1 citations

Alexandre V. Hirayama, Erik L. Kimble, Andrew J. Portuguese, Aya Albittar, Aude G. Chapuis +8 more

Unveiling the proteome-wide autoreactome enables enhanced evaluation of emerging CAR T cell therapies in autoimmunity

Journal of Clinical Investigation(2024)10.1172/jci180012

N/A

0DataRank · unranked

44 citations

David Yu, Alysa Rallistan, Müge Kalaycıoğlu, Jim Boonyaratanakornkit, Damian J. Green +29 more

Development and validation of predictive models of early immune effector cell–associated hematotoxicity

Blood Advances(2024)10.1182/bloodadvances.2024014455

N/A

0DataRank · unranked

10 citations

Jennifer J. Huang, Andrew J. Portuguese, Valentín Ortiz‐Maldonado, Aya Albittar, Natalie Wuliji +28 more

Stealth transgenes enable CAR-T cells to evade host immune responses

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008417

N/A

0DataRank · unranked

16 citations

Trisha R. Berger, Michael C. Kann, Harrison Silva, Rebecca C. Larson, Mark B. Leick +8 more

Targeting the membrane-proximal C2-set domain of CD33 for improved CAR T cell therapy

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200854

N/A

0DataRank · unranked

9 citations

Sheryl Y.T. Lim, George S. Laszlo, Erik L. Kimble, Tinh-Doan Phi, Margaret C. Lunn-Halbert +6 more

A stochastic framework for evaluating CAR T cell therapy efficacy and variability

Mathematical Biosciences(2024)10.1016/j.mbs.2024.109141

N/A

0DataRank · unranked

5 citations

Tuan Anh Phan, Cameron J. Turtle, Jianjun Paul Tian, C.-T. Hoang

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

UNC Libraries(2024)10.17615/h0gs-sd07

N/A

0DataRank · unranked

1 citations

Michael K. Mansour, Zhen‐Huan Hu, Mary M. Horowitz, Peiman Hematti, Miguel‐Angel Perales +6 more

qPCR assay for detection of Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Elements from CAR-T and TCR-T cells in fresh and formalin-fixed tissue

PLoS ONE(2024)10.1371/journal.pone.0303057

N/A

0DataRank · unranked

0 citations

Graeme C. Black, Marie Bleakley, Denise Buenrostro, Aude G. Chapuis, Alexandre V. Hirayama +12 more

Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-009890

N/A

0DataRank · unranked

14 citations

Matthew J. Frigault, Michael Heim, S.R. Foley, Brian T. Hill, Grant Schofield +14 more

New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024015599

N/A

0DataRank · unranked

5 citations

Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop, Temitope Oloyede +40 more

Chimeric antigen receptor T‐cell therapy for high‐grade B‐cell lymphoma NOS

British Journal of Haematology(2025)10.1111/bjh.70020

N/A

0DataRank · unranked

2 citations

Kwang Woo Ahn, Jinalben Patel, Qinghua Lian, Muhammad Bilal Abid, Ahmed Al Nughmush +18 more

Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in rhesus macaques

Blood Advances(2025)10.1182/bloodadvances.2024015016

N/A

0DataRank · unranked

4 citations

Stefan Radtke, Greta Kanestrom, Emily Fields, Olivier Humbert, Salvatore Fiorenza +11 more

Influence of B cell or plasma cell-targeted CAR-T cell therapy on humoral immunity and vaccine immunogenicity: The HICAR study

Research Square(2025)10.21203/rs.3.rs-7061163/v1

N/A

0DataRank · unranked

0 citations

Stosh Ozog, Elizabeth M. Krantz, Karyn Tindbaek, Julián B. Muñoz, Winnie Liu +16 more

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

Blood(2020)10.1182/blood.2020006216

N/A

0DataRank · unranked

67 citations

Sarah Nikiforow, Michael K. Mansour, Zhen‐Huan Hu, Mary M. Horowitz, Marcie Riches +6 more

Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy

medRxiv(2021)10.1101/2021.05.10.21256634

N/A

0DataRank · unranked

7 citations

Andrea N. Loes, Kiel Shuey, Elizabeth M. Krantz, Jim Boonyaratanakornkit, Jacob Keane-Candib +13 more

Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure

Blood(2020)10.1182/blood.2019002936

N/A

0DataRank · unranked

321 citations

Alexandre V. Hirayama, Janaki Purushe, Kevin A. Hay, James Lymp, Daniel H. Li +12 more

CD19 CAR T-cell product type independently impacts CRS and ICANS severity in patients with aggressive NHL.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7532

N/A

0DataRank · unranked

5 citations

Aisling Cearley, Paula Perkins, Angela Kirk, Mazyar Shadman, Staci Williamson +10 more

Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL

Blood(2022)10.1182/blood.2021014497

N/A

0DataRank · unranked

54 citations

Nicolas Gazeau, Alexandre V. Hirayama, Joshua A. Hill, Vicky Wu, Aisling Cearley +17 more